-
2
-
-
0025060806
-
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
-
Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
-
(1990)
N Engl J Med
, vol.322
, pp. 352-358
-
-
Moertel, C.G.1
Fleming, T.R.2
Macdonald, J.S.3
-
3
-
-
0023855192
-
Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP Protocol C-01
-
Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP Protocol C-01. J Natl Cancer Inst 1988;80:30-36.
-
(1988)
J Natl Cancer Inst
, vol.80
, pp. 30-36
-
-
Wolmark, N.1
Fisher, B.2
Rockette, H.3
-
4
-
-
0025832661
-
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584
-
Steele G Jr, Bleday R, Mayer RJ, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991;9:1105-12.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1105-1112
-
-
Steele G., Jr.1
Bleday, R.2
Mayer, R.J.3
-
5
-
-
0031052731
-
Liver resection for colorectal metastases
-
Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
-
(1997)
J Clin Oncol
, vol.15
, pp. 938-946
-
-
Fong, Y.1
Cohen, A.M.2
Fortner, J.G.3
-
6
-
-
0344051547
-
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
-
Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 252-258
-
-
-
7
-
-
0029766212
-
Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver
-
Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Cancer 1996;78:1639-45.
-
(1996)
Cancer
, vol.78
, pp. 1639-1645
-
-
Harmantas, A.1
Rotstein, L.E.2
Langer, B.3
-
8
-
-
0028104996
-
Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma
-
Kemeny N, Conti JA, Campana P, et al. Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-95.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2288-2295
-
-
Kemeny, N.1
Conti, J.A.2
Campana, P.3
-
9
-
-
0025054330
-
A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver
-
Wagman LD, Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8:1885-93.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1885-1893
-
-
Wagman, L.D.1
Kemeny, M.M.2
Leong, L.3
-
10
-
-
0029998250
-
Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases
-
Okuno K, Shigeoka H, Lee YS, et al. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases. Hepato-gastroenterology 1996;43:688-91.
-
(1996)
Hepato-gastroenterology
, vol.43
, pp. 688-691
-
-
Okuno, K.1
Shigeoka, H.2
Lee, Y.S.3
|